| DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
| DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
| DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
| DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
| DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
| DAA829 |
Decrease in amplitude of peristaltic pressure wave in upper esophogeal sphincter |
Physiological |
oesophagus |
Human |
— |
— |
|
| DAA832 |
Decrease in number of acinar cells |
Physiological |
salivary gland |
Human |
— |
— |
|
| DAA852 |
Deficiencies in generating secondary peristaltic contractions |
Physiological |
oropharynx, oesophagus |
Human |
— |
— |
|
| DAA852 |
Deficiencies in generating secondary peristaltic contractions |
Physiological |
oropharynx, oesophagus |
Human |
— |
— |
|
| DAA1518 |
demethyl-Q 7 |
Molecular |
liver |
Mouse |
Coq7 |
10.0% Increase Gene Expression Level |
|
| DAA825 |
Dental wear and tear |
Physiological |
tooth |
Human |
— |
— |
|
| DAA613 |
Diabetes mellitus |
Pathological |
pancreas |
Human |
— |
SeriesMorbidity |
|
| DAA830 |
Diminishing of glandular secretions |
Physiological |
alimentary system |
Human |
— |
— |
|
| DAA835 |
D-xylose absorption decreases |
Physiological |
alimentary system |
Human |
— |
— |
|
| DAA850 |
Dysphagia incidence increases |
Physiological |
oropharynx, oesophagus |
Human |
— |
— |
|
| DAA850 |
Dysphagia incidence increases |
Physiological |
oropharynx, oesophagus |
Human |
— |
— |
|
| DAA1522 |
ectonucleoside triphosphate diphosphohydrolase 2 |
Molecular |
liver |
Mouse |
Entpd2 |
23.0% Increase Gene Expression Level |
|
| DAA1035 |
Edentulism (Tooth Loss) (Female) |
Pathological |
tooth |
Human |
— |
SeriesIncidence |
|
| DAA1034 |
Edentulism (Tooth Loss) (Male) |
Pathological |
tooth |
Human |
— |
SeriesIncidence |
|
| DAA1558 |
enhancer of polycomb homolog 1 (Drosophila) |
Molecular |
liver |
Mouse |
Epc1 |
2.0% Increase Gene Expression Level |
|
| DAA858 |
Enteric neuron loss |
Physiological |
alimentary system |
Human |
— |
— |
|
| DAA853 |
Esophageal acid contact time increased |
Physiological |
oesophagus |
Human |
— |
— |
|
| DAA2585 |
Exocrine pancreatic function unchanged |
Physiological |
pancreas |
Human |
— |
— |
|
| DAA1537 |
forkhead box A3 |
Molecular |
liver |
Mouse |
Foxa3 |
13.0% Increase Gene Expression Level |
|
| DAA1521 |
fos-like antigen 2 |
Molecular |
liver |
Mouse |
Fosl2 |
40.0% Decrease Gene Expression Level |
|